Interstitial Lung Disease

Interstitial Lung Disease

Diagnosis of interstitial lung disease (ILD) is a complex yet crucially important component of providing appropriate prognostic counseling and therapeutic interventions. The plots summarize all 1767 patients seen in 2019 by Cleveland Clinic’s interstitial lung disease team and who had more than 1 visit to the center. These data demonstrate the value added by experienced comprehensive, multidisciplinary evaluations performed in the high volume center.

Multidisciplinary Diagnosis of Interstitial Lung Disease Patients by the ILD Team (N = 1767)

2019

ILD – interstitial lung disease

Of patients with a suspected referring diagnosis, 45% (617 of 1115) were found to carry an alternative diagnosis after a comprehensive assessment; 80% of patients referred without a defined diagnosis had a specific diagnosis rendered by the end of 2019.

IPF – idiopathic pulmonary fibrosis

For the most deadly interstitial lung disease, idiopathic pulmonary fibrosis (IPF), nearly 30% of patients referred with the diagnosis of IPF were found to have an alternate explanation (81 of 279 referrals).